Capricor Therapeutics Inc (CAPR):企業の財務・戦略的SWOT分析

◆英語タイトル:Capricor Therapeutics Inc (CAPR) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH485930FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥66,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥99,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Capricor Therapeutics Inc (Capricor) is a biotechnology company that discovers, develops and commercializes biological therapeutics for the treatment of rare disorders. The company offers cardiac cell therapy and cenderitide products for the treatment of post myocardial infarction, advanced heart failure and duchenne muscular dystrophy associated cardiomyopathy. Capricor lead candidate CAP- 1002 is an allogeneic cardiosphere-derived cell product which is in phase II clinical stage for the treatment of adult cardiology indications. The company offers research programs on cell therapy, natriuretic peptides and exosome platforms. Capricor also conducts clinical trials for the development of novel therapeutics to prevent and treat cardiac and other serious medical conditions. Capricor is headquartered in Beverly Hills, California, the US.

Capricor Therapeutics Inc Key Recent Developments

Mar 11,2021: Capricor Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
Nov 24,2020: Capricor Therapeutics Commences Dosing Patients in Phase 2 Trial of CAP-1002 in Patients with Severe COVID-19
Nov 12,2020: Capricor Therapeutics reports third quarter 2020 financial results and provides corporate update
Aug 06,2020: Capricor Therapeutics reports second quarter 2020 financial results and provides corporate update
May 14,2020: Capricor Therapeutics reports first quarter 2020 financial results and provides corporate update

This comprehensive SWOT profile of Capricor Therapeutics Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Capricor Therapeutics Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Capricor Therapeutics Inc – Key Information
Capricor Therapeutics Inc – Overview
Capricor Therapeutics Inc – Key Employees
Capricor Therapeutics Inc – Key Employee Biographies
Capricor Therapeutics Inc – Key Operational Heads
Capricor Therapeutics Inc – Major Products and Services
Capricor Therapeutics Inc – History
Capricor Therapeutics Inc – Company Statement
Capricor Therapeutics Inc – Locations And Subsidiaries
Capricor Therapeutics Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Capricor Therapeutics Inc – Business Description
Capricor Therapeutics Inc – Corporate Strategy
Capricor Therapeutics Inc – SWOT Analysis
SWOT Analysis – Overview
Capricor Therapeutics Inc – Strengths
Capricor Therapeutics Inc – Weaknesses
Capricor Therapeutics Inc – Opportunities
Capricor Therapeutics Inc – Threats
Capricor Therapeutics Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Capricor Therapeutics Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Capricor Therapeutics Inc, Key Information
Capricor Therapeutics Inc, Key Ratios
Capricor Therapeutics Inc, Share Data
Capricor Therapeutics Inc, Major Products and Services
Capricor Therapeutics Inc, History
Capricor Therapeutics Inc, Key Employees
Capricor Therapeutics Inc, Key Employee Biographies
Capricor Therapeutics Inc, Key Operational Heads
Capricor Therapeutics Inc, Other Locations
Capricor Therapeutics Inc, Subsidiaries
Capricor Therapeutics Inc, Key Competitors
Capricor Therapeutics Inc, SWOT Analysis
Capricor Therapeutics Inc, Ratios based on current share price
Capricor Therapeutics Inc, Annual Ratios
Capricor Therapeutics Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Capricor Therapeutics Inc (CAPR):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • DTE Energy Co (DTE):企業の財務・戦略的SWOT分析
    DTE Energy Co (DTE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • DexTech Medical AB:製薬・医療:M&Aディール及び事業提携情報
    Summary DexTech Medical AB (DexTech) is a research company that conducts research in the areas of urological oncology, mainly within prostate cancer. The company develops product candidates based on a modified carbon hydrate molecule combined with active substances such as generics. Its technology p …
  • Linedata Services SA (LIN):企業の財務・戦略的SWOT分析
    Linedata Services SA (LIN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Richter Gedeon Nyrt (RICHTER)-医療機器分野:企業M&A・提携分析
    Summary Richter Gedeon Nyrt (Richter) is a pharmaceutical company that develops, manufactures and commercializes a wide range of drugs including original, generic and licensed products and over-the-counter (OTC) medicines. The company’s product portfolio encompasses medicines to treat gynaecological …
  • Dixons Carphone plc:企業の戦略・SWOT・財務情報
    Dixons Carphone plc - Strategy, SWOT and Corporate Finance Report Summary Dixons Carphone plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • WESCO International, Inc.:企業の戦略・SWOT・財務分析
    WESCO International, Inc. - Strategy, SWOT and Corporate Finance Report Summary WESCO International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Questerre Energy Corp (QEC):石油・ガス:M&Aディール及び事業提携情報
    Summary Questerre Energy Corp (Questerre) is an independent oil and gas exploration and development company that acquires, explores, develops and produces unconventional oil and gas properties. The company’s unconventional properties include tight oil, shale oil and shale gas. It has base production …
  • Sharps Compliance Corp (SMED):企業の財務・戦略的SWOT分析
    Summary Sharps Compliance Corp (Sharps) is a healthcare waste solution company that offers regulatory compliant services. The company offers products such as sharps disposal systems, public sharps safety, takeaway medication recovery system, collection and disposal system, complete needle collection …
  • Tokyo Gas Co Ltd (9531)-石油・ガス分野:企業M&A・提携分析
    Summary Tokyo Gas Co Ltd (Tokyo Gas) is a gas utility that produces, supplies and markets liquefied natural gas (LNG). It also produces, supplies and sells electricity. Tokyo Gas also has overseas upstream, midstream and downstream businesses. It provides engineering solutions, gas appliances and ga …
  • Brii Biosciences:製薬・医療:M&Aディール及び事業提携情報
    Summary Brii Biosciences is an independent biotechnology company that focuses on developing and commercializing innovative medicines for infectious diseases, liver and lung diseases, and other chronic diseases. The company strives to advance breakthroughs in science and technology, and enable patien …
  • Puretech Health plc (PRTC):企業の財務・戦略的SWOT分析
    Summary Puretech Health Plc (Puretech), formerly PureTech Ventures LLC, is a biopharmaceutical company that develops medicines for diseases caused by dysfunction in the nervous, gastrointestinal, and immune systems. The company develops a microbiome immune system drug-discovery platform and drug can …
  • Davos Life Science Pte Ltd:企業の戦略・SWOT・財務情報
    Davos Life Science Pte Ltd - Strategy, SWOT and Corporate Finance Report Summary Davos Life Science Pte Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Trinity Industries Inc (TRN):企業の財務・戦略的SWOT分析
    Trinity Industries Inc (TRN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • The New York Times Company (NYT):企業の財務・戦略的SWOT分析
    The New York Times Company (NYT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • VAALCO Energy Inc (EGY):企業の財務・戦略的SWOT分析
    VAALCO Energy Inc (EGY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Rosenergoatom Concern:電力:M&Aディール及び事業提携情報
    Summary Rosenergoatom Concern (Rosenergoatom) is a subsidiary of Atomenergoprom, which is electric power generation company, mainly supplying electrical and thermal energy in Russia. The company’s major activities include design, construction, operation and decommissioning of nuclear power plants. T …
  • Vivartia Holdings SA.:戦略・SWOT・企業財務分析
    Vivartia Holdings SA. - Strategy, SWOT and Corporate Finance Report Summary Vivartia Holdings SA. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • ASCO Group Ltd-石油・ガス分野:企業M&A・提携分析
    Summary ASCO Group Limited (ASCO) is a provider of supply chain management services to the global oil and gas sector and other related industries. The company offers a broad range of services covering logistics, fuels and lubricants, freight forwarding and environmental and waste management services …
  • Blackbird Plc (BIRD):企業の財務・戦略的SWOT分析
    Summary Blackbird plc (Blackbird), formerly Forbidden Technologies plc, is a technology company that develops and commercializes cloud-based video technology. The company offers products such as FORscene- cloud-based post-production platform, captevate- online video editor and eva-video social netwo …
  • Deep Down Inc (DPDW):企業の財務・戦略的SWOT分析
    Summary Deep Down Inc (Deep Down) is a subsea oilfield services company that offers exploration and production support products and services. The company provides products such as active heave compensator, asset wellness, bend limiters, bend stiffener latcher, buoyancy modules, carousels, dynamic po …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆